Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

14.38
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
9.16
Today|||52-Week Range
17.55
-14.66%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close14.38
Today’s openn.a.
Day’s range14.33 - 15.25
Volume104,341
Average volume (3 months)1,113,977
Market cap$2.0B
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-56.21%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book315.24

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...0.000.00%
EXELExelixis Inc0.000.00%
PRAHPRA Health Sciences ...0.000.00%
ABCOAdvisory Board Co0.000.00%
Data as of 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs